肝癌边缘CT强化特征与肿瘤新生血管的相关性研究

doi:10.3969/j.issn.1672-5069.2011.02.020

Abstract

Abstract: Objective To investigate the correlation between the enhancement characteristics and tumor angiogenesis in the edge of hepatocellular carcinoma. Methods The characteristics of CT enhancement confirmed by preoperative CT scan and contrast CT of hepatic arterial and portal phase were studied in 38 patients with hepatocellular carcinoma. CD34 was detected by immunohistochemistry in the tumor tissues. Results The tumors with clear edge shown on plain CT with thin or thick envelope were in the manner of expansive growth，while the tumors with unclear edge were in invasive growth；there was a higher probability of invasion for tumors with unclear and high-density，and a probable transfer for tumors with rich edge angiogenesis；relatively，there was lower transfer for tumors with low-density and fewer new blood vessels. Conclusion Dynamic enhanced CT scan can show the CT enhancement characteristics of the tumor，which might reflect the pathological changes and have great significance for clinical guidance.

Key words: Hepatocellular carcinoma, CD-34, Pathology, X-ray computed tomography

SHI Huiping，LIU Xiaoyu，LI Dongmei，et al.. The correlation between CT enhancement patterns and tumor angiogenesis in the edge of hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2011, 14(2): 138-141.

References

[1] 周四喜，刘劲华，庄景凡，等. 原发性肝癌临床特点分析[J]. 实用肝脏病杂志，2007，10（3）：170-171.
[2]　 ICHIKAWA T，KITAMURA T，NAKAJIMA H，et al. Hypervascular hepatocellular carcinoma can double arterial phase imaging with multi-detector CT improve tumor depiction in the cirrhotic liver[J]. Am J Roentgenol，2004，179（3）:751-758.
[3]　 MURAKAMA T，KIM T，TAKAMURA M，et al. Hypervascular hepatocellular carcinoma detection with double arterial phase multi-detector row helical CT[J]. Radiology，2001，218（3）:763-767.
[4] SCHIMA W，HAMMERSTING R，CATALANO C，et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate[J]. Am J Roentgenol，2006，186（6）:1571-1579.
[5] MUCELLI RMP，COMO C，FRATE CD，et al. Multidetector CT with double arterial phase and high-iodine-concentration contrast agent in the detection of hepatocellular carcinoma[J]. Radiol Med，2006，111（2）:181-191.
[6] GRAZIOLI L，OLIVETTI L，FUGAZZOLA C，et al.The pseudocapsule in hepatocellular carcinoma:correlation between dynamic MR imaging and pathology[J]. Eur Radiol，1999，9（1）:62-67.
[7] WEIDNER N，SEMPLE JP，WELCH WR，et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J]. N Engl J Med，1991，324（1）:1-8.
[8] XU YK，CHENG TM，LIU XY，et a. l. Preliminary study on the relationship between CT marginal features of massive hepatocellular carcinoma and intratumorous microvascular density[J]. Radiol Pract，2000，15（1）:30-32.
[9] KARAHAN OI，YIKILMAZ A，ISIN S，et al. Characterization of hepatocellular carcinomas with triphasic CT and correlation with histopathologic findings[J]. Acta Radiol，2003，44（6）:566-571.
[10] KIM HC，KIM TK，SUNG KB，et al. Preoperative evaluation of hepatocellular carcinoma:combined use of CT with arterial portography and hepatic arteriography[J]. AJR，2003，180（6）:1593-1599.
[11] 李大庆，舒圣捷，姜慧杰. 双期动态增强螺旋CT评价原发性肝细胞癌边缘血供情况[J]. 医学影像学杂志，2008，18（3）：275-277.
[12] SUN HC，TANG ZY，LI XM，et al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis[J]. J Cancer Res Clin Oncol，1999，125（7）:419-426.
[13] SALIZZONI M，ROMAGNOLI R，LUPO F，et al. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation[J]. Transplantation，2003，76（5）:844-848.
[14] OHMORI S，SHIRAKI K，SUGIMOTO K，et al. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases[J]. Hum Pathol，2001，32（12）:1363-1370.
[15] TANIGAWA N，LU C，MITSUI T，et al. Quantitaion of sinusoidlike vessels in hepatocellular carcinoma: its clinical and prognostic significance[J]. Hepatology，1997，26（5）:1216-1223.
[16] SUZUKI K，HAYASHI N，MIYAMOTO Y，et al. Expression of vascula permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma[J]. Cancer Res，1996，56（13）:3004-3009.
[17] CAO G，KURIYAMA S，DU P，et al. Complete regression of establishe murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer[J]. Gastroenterology，1997， 112（2）:501-510.
[18] SEMELKA RC，HUSSAIN SM，MARCOS HB，et al. Perilesional enhancement of hepaticmetastases:correlation between MR imaging and histopathologic findings-initial observations[J]. Radiology，2000，215（1）:89-94.
[19] UEDA K，MATSUI O，KAWAMORI Y，et al. Hypervascular hepatocelluar carcinoma:evaluation of hemodynamics with dynamic CT during hepatic arteriography[J]. Radiology，1998，206（1）:161-166.
[20] 卢炳丰，黄仲奎，龙莉玲. 小肝癌的病理与螺旋CT诊断[J]. 实用放射学杂志，2005，21（6）：648-651.

The correlation between CT enhancement patterns and tumor angiogenesis in the edge of hepatocellular carcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[2]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[3]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[4]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[5]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[6]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[7]	Qiao Zhizhong. Value of contrast-enhanced ultrasonography in differential diagnosis of patients with focal nodular hyperplasia and hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 421-424.
[8]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[9]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[10]	Lin Lan, Shen Min, Ruan Jianwen.. Expression of programmed death receptor 1 in liver tissue of patients with autoimmune hepatitis and its clinical implications [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 204-207.
[11]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[12]	Xing Diankui, Cheng Jing. Clinical value of ¹⁸F-FDG PET/CT scan in patients with hepatocellular carcinoma and hepatic microvascular invasion [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 252-254.
[13]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[14]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[15]	Wang Zhaoxia, Guan Ke, Fu Sanxian, Wang Huijie. Early administration of enteral nutrition in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 272-275.